1 – 5 of 46
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology
(
- Contribution to journal › Article
-
Mark
100 ancient genomes show repeated population turnovers in Neolithic Denmark
(
- Contribution to journal › Article
-
Mark
Population genomics of post-glacial western Eurasia
(
- Contribution to journal › Article
- 2023
-
Mark
Digital lifestyle treatment improves long-term metabolic control in type 2 diabetes with different effects in pathophysiological and genetic subgroups
(
- Contribution to journal › Article
- 2022
-
Mark
The role of circulating galectin-1 in type 2 diabetes and chronic kidney disease : evidence from cross-sectional, longitudinal and Mendelian randomisation analyses
(
- Contribution to journal › Article